The approval by the United States Food and Drug Administration (USFDA) is for marketing Bosentan tablets in the strengths of 62.5 mg and 125 mg, Lupin said in a statement. from Moneycontrol Business News http://bit.ly/2ZDtkjQ
The five-year close-ended scheme was fully funded in April 2014 and had raised Rs 238 crore in assets under management. from Moneycontrol Business News http://bit.ly/2ZMzspV
Bombay Dyeing shares plunged 9.78 percent to close at Rs 112.60 on the BSE. During the day, it tumbled 17.42 percent to Rs 103.05. from Moneycontrol Business News http://bit.ly/2UKyQxu
Revenue from operations rose to 4,384.02 crore, compared with Rs 4,007.24 crore a year ago, TVS Motor Company said in a regulatory filing. from Moneycontrol Business News http://bit.ly/2LmZ1eq
The key reasons for the downward revision are the prediction of lower-than-normal monsoon for 2019 and continued agrarian distress, and the loss of momentum in the industrial output growth, especially manufacturing and electricity. from Moneycontrol Business News http://bit.ly/2VFXRhI
The standalone revenue from operations in the October-December period increased to Rs 27.33 crore from Rs 5.68 crore in the year-ago period, Gammon India said in a filing to BSE. from Moneycontrol Business News http://bit.ly/2GOrZxU